INTRODUCTION
Phagocytosis of zymosan particles by human peripheral blood polymorphonuclear leukocytes (PMN) results in the release of lysosomal enzymes into the extracellular medium (1) and enhanced glucose oxidation and lactate production (2) . The antibiotic, cytochalasin B (CB), inhibits phagocytosis by PMN (3, 4) , presumably by interfering with the membrane-associated network of microfilaments (5) . CB is therefore useful in studies of the interrelationship between phagocytosis and metabolic changes in stimulated PMN .
This study confirms earlier reports that CB inhibits phagocytosis by PMN (3, 4, 6) and carbohydrate metabolism in phagocytosing PMN (4, 6, 7) . The release of the lysosomal enzyme, ,3-glucuronidase, however, was moderately stimulated by CB under conditions which resulted in almost total inhibition of phagocytosis .
MATERIALS AND METHODS
Zymosan (Sigma Chemical Co ., St . Louis, Mo.) was incubated for 1 h at 37°C with plasma from the donor of cells used in the experiment, collected by centrifugation, and suspended in Krebs-Ringer phosphate buffer (KRP) (8) . CB (Imperial Chemical Industries, Macclesfield, Cheshire, England) was dissolved in dimethylsulfoxide (DMSO) before addition to the incubation medium. [1_14 Qglucose and Heparinized blood (10 U heparin/ml blood) was obtained from normal women. The donors abstained from all dietary sources of methyl xanthines on the morning blood was drawn . After erythrocytes were allowed to sediment at 37°C for 2-3 h, the plasma (containing leukocytes) was removed and centrifuged at 250 g for 10 min . The cell pellet was suspended in plasma, and 3 vol of 0.87°/0 NH4C1 were added to lyse remaining erythrocytes . Leukocytes were then washed twice in KRP and suspended in buffer for incubation . Suspensions (ca. 108 cells/ml) contained 95-98% PMN .
Separate aliquots of cell suspensions were used for measurements of inulin uptake and /3-glucuronidase release, and for measurement of 14002 and lactate production . 0 .2 ml of cell suspension was added to polyethylene test tubes containing 5 gl of DMSO with the desired concentration of CB and preincubated for 30 min. 0 .2 ml of KRP containing glucose (5 mM, final concentration) with or without zymosan (1 mg/ml, final concentration) was then added, and incubation was continued for an additional 30 min for metabolic measurements . Trace concentrations of Cell suspensions were incubated in polyethylene test tubes at 37°C with continuous shaking . When [ 14 C ] inulin was present, the incubation was stopped by chilling the tubes in an ice bath and the addition of chilled KRP containing inulin, I mg/ml . The cell suspension was centrifuged at 250g for 5 min, and the supernatant was saved for determination of (3-glucuronidase activity, using p-nitrophenyl glucuronide as substrate (9) . In some experiments, total enzyme activity was determined in selected tubes by the addition of Triton-X100 (1) . For measurement of [ 14 C] inulin uptake, the cell pellet was washed as described by Berger and Karnovsky (10) , dissolved in 0.1 ml of 2 N NaOH, and diluted with 1 .4 ml H20. Aliquots were taken for counting in a 3a40 liquid scintillator (Research Products International Corp ., Elk Grove Village, Ill .) and for protein determinations (11) . The incubation of cell suspensions containing [1-14C] glucose was stopped by the injection of 0.5 ml of 1 N HC1O4 into the medium. t4C02 was collected in hyamine and counted (12) . Lactate was measured in the deproteinized fluid (13) .
RESULTS
The results of preliminary experiments indicated that preincubation of cells with CB, 50 µg/ml, did not alter baseline j -glucuronidase release from nonphagocytosing cells, although the antibiotic has been shown to inhibit the metabolism of glucose by resting cells (4, 6, 7) . Zymosan added to cells preincubated without CB, stimulated the uptake of [ 14 C] inulin and the release of $-glucuronidase from cells, as well as the oxidation of [l-14 C]glucose to 14 002 and the production of lactate . Previous incubation with CB in concentrations ranging from 2 to 60 µg/ml resulted in inhibition of zymosan-stimulated [ 14C]inulin uptake, and 14G0 2 and lactate production . The release of f3-glucuronidase was slightly stimulated at all concentrations of the antibiotic used (Fig . 1) .
CB inhibits the transport of 2-deoxy-D-glucose into horse leukocytes (14) , and of glucose into hepatoma cells (15) . Our findings could have re- suited from inhibition of glucose utilization by cells incubated with CB . Therefore, we tested the effect of glucose on zymosan-stimulated [ 14C]-inulin uptake and jQ-glucuronidase release . Glucose had no significant effect on either inulin uptake or enzyme release by resting or phagocytosing cells (Table I) .
DISCUSSION
CB has been shown to inhibit phagocytosis by human PMN as measured by the uptake and killing of bacteria (3, 4, 6) or by the direct examination of cells incubated with particles (4, 6) . The difficulties inherent in these methods have been discussed (4, 10) . We have elected to use the uptake of [ 14C] inulin into cells as an index of phagocytosis, as described previously (10) . This large molecular weight compound presumably enters cells in the water taken into the phagocytic vesicle . Water also enters cells during the process of pinocytosis . The uptake of [19C]inulin, therefore, serves as an index of endocytosis, and is not specific for either phagocytosis or pinocytosis (10) . Since endocytosis of either type is associated with metabolic changes (16), it is reasonable to relate PMN metabolism and function to [14C]-inulin uptake . Three possible mechanisms have been proposed for the release of lysosomal enzymes from phagocytosing cells (1) . The first, release of enzymes after cell death, cannot account for release of lysosomal enzymes from PMN phagocytosing I No zymosan I Zymosan, 1 mg/ml zymosan, since lactic dehydrogenase, a nonlysosomal cytoplasmic enzyme, is not released from cells in response to zymosan (1) .
A second mechanism which has been proposed is that of "regurgitation during feeding ." Electron microscope examination of rabbit neutrophils phagocytosing zymosan particles (17) has suggested that lysosomes fuse with the phagocytic vesicle as it forms during particle uptake . The lysosomes appear to discharge their content of enzymes into the vesicle . Enzymes are then extruded through the unclosed "mouth" of the phagocytic vesicle . Henson (17) has suggested that neutrophils which have phagocytosed many particles "run out of energy" and become inefficient in closing off developing phagocytic vesicles . Lysosomal enzymes which have been extruded into the vesicle are allowed to leak out into the medium . Since CB inhibits glucose metabolism (14, 15) , it is possible that the early phases of phagocytosis occur in the presence of CB, but that the antibiotic deprives the cells of sufficient energy to close off the mouth of the vesicle . However, the observation that complete deprivation of the cells of exogenous glucose does not mimick the effects of CB argues against this possibility .
We favor a third mechanism, "directed exocytosis," or "reverse endocytosis," proposed for the stimulation of release of enzyme by zymosan . Phagocytosis is apparently not required for the particles to stimulate enzyme release . It thus appears possible that zymosan, by coming into contact with cell membrane receptors, triggers lysosomal enzyme release without the requirement for the development of a phagocytic vesicle .
Orci et al . observed that CB enhances glucoseinduced secretion of insulin by isolated rat pancreatic islets (18) . They suggested that the network of microfilaments of the beta cell might act as a barrier which denies the insulin-secretory granules access to the cell membrane . CB, by disrupting the function of this network, could cause enhancement of insulin secretion . A similar mechanism could explain the moderate enhancement of zymosan-stimulated (3-glucuronidase release from PMN . 
